The interactions between variants of GALT in Galactosemia: In-silico Approach
DOI:
https://doi.org/10.59415/ijfas.v7i3.123Keywords:
Galactosemia In-silico mutations GALTAbstract
The In-silico studies encourages design of the drug molecules, understanding and development of the pathways, protein-protein interactions, stability of the molecules etc. these studies also help in identifying the disorders and in turn to derive the new drug molecules. Galactosemia is one of the metabolic disorders that affect the metabolism of the sugar galactose. It leads to accumulation of the galactose in the blood leading to quite morbidity and genetic disorders.
The current paper discuss about the interactions between the variants of Galactose-1 -phosphate uridylyltransferase (GALT).
Using the Mutater software, the mutations N314D, S135L K285N and Q188R were incorporated in the sequence of the unmutated GALT.
Published
Issue
Section
License
Copyright (c) 2022 International Journal of Fundamental and Applied Sciences (IJFAS)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
License Statement
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors who publish with International Journal of Fundamental and Applied Sciences (IJFAS) retain copyright of their articles and grant the journal the right of first publication.
This license allows others to share, use, and build upon the work—commercially or non-commercially—as long as appropriate credit is given to the original authors and source, and any changes are indicated.
The journal encourages open access and supports the free exchange of knowledge while ensuring proper attribution of original work.
